Showing items 1–100
Bipyrazole derivatives as JAK inhibitors
Grant US-11905275-B2
United States of America
Sustained-release dosage forms of ruxolitinib
Grant US-11896717-B2
United States of America
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant US-11851442-B2
United States of America
JAK1 pathway inhibitors for the treatment of cytokine-related disorders
Grant US-11833152-B2
United States of America
Combination therapy for treatment of myeloproliferative neoplasms
Grant US-11833155-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus…
Grant US-11744832-B2
United States of America
Processes of preparing a JAK1 inhibitor
Grant US-11685731-B2
United States of America
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
Grant US-RE49445-E1
United States of America
Topical formulation for a JAK inhibitor
Grant US-11590136-B2
United States of America
Bipyrazole derivatives as JAK inhibitors
Grant US-11591318-B2
United States of America
Sustained-release dosage forms of ruxolitinib
Grant US-11576865-B2
United States of America
Sustained-release dosage forms of ruxolitinib
Grant US-11576864-B2
United States of America
Topical formulation for a JAK inhibitor
Grant US-11571425-B2
United States of America
Inhibitors of histone deacetylase
Grant US-RE49240-E1
United States of America
Sustained-release dosage forms of ruxolitinib
Grant US-11337927-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus…
Grant US-11331320-B2
United States of America
Treatment of hidradenitis suppurativa using JAK inhibitors
Grant US-11304949-B2
United States of America
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant US-11285140-B2
United States of America
Low dose combination therapy for treatment of myeloproliferative neoplasms
Grant US-11278541-B2
United States of America
Topical formulation for a JAK inhibitor
Grant US-11219624-B2
United States of America
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
Grant US-11214573-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-11207302-B2
United States of America
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
Grant US-11192868-B2
United States of America
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant US-11161855-B2
United States of America
Sustained release dosage forms for a JAK1 inhibitor
Grant US-11045421-B2
United States of America
Bipyrazole derivatives as JAK inhibitors
Grant US-11001571-B2
United States of America
Processes and intermediates for making a JAK inhibitor
Grant US-10899736-B2
United States of America
Sustained-release dosage forms of ruxolitinib
Grant US-10874616-B2
United States of America
Topical formulation for a JAK inhibitor
Grant US-10869870-B2
United States of America
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
Grant US-RE48285-E1
United States of America
Topical formulation for a JAK inhibitor
Grant US-10758543-B2
United States of America
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant US-10695337-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-10653677-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus…
Grant US-10639310-B2
United States of America
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK…
Grant US-10640506-B2
United States of America
Low dose combination therapy for treatment of myeloproliferative neoplasms
Grant US-10596161-B2
United States of America
Sustained release dosage forms for a JAK1 inhibitor
Grant US-10561616-B2
United States of America
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
Grant US-10513522-B2
United States of America
Processes of preparing a JAK1 inhibitor and new forms thereto
Grant US-10450325-B2
United States of America
Bipyrazole derivatives as JAK inhibitors
Grant US-10435392-B2
United States of America
Janus kinase inhibitors and uses thereof
Grant US-10399979-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus…
Grant US-10398699-B2
United States of America
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant US-10370387-B2
United States of America
1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-10369137-B2
United States of America
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
Grant US-10280157-B2
United States of America
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
Grant US-10208002-B2
United States of America
Sustained-release dosage forms of ruxolitinib
Grant US-10166191-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-10034864-B2
United States of America
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant US-9999619-B2
United States of America
Inhibitors of histone deacetylase
Grant US-9988343-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus…
Grant US-9974790-B2
United States of America
Bipyrazole derivatives as JAK inhibitors
Grant US-9926301-B2
United States of America
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant US-9908895-B2
United States of America
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
Grant US-9873688-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus…
Grant US-9814722-B2
United States of America
Processes of preparing a JAK1 inhibitor and new forms thereto
Grant US-9802957-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-9789094-B2
United States of America
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant US-9777017-B2
United States of America
Processes and intermediates for making a JAK inhibitor
Grant US-9718834-B2
United States of America
Processes and intermediates for making a JAK inhibitor
Grant US-9714233-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as janus…
Grant US-9662335-B2
United States of America
Sustained release dosage forms for a JAK1 inhibitor
Grant US-9655854-B2
United States of America
3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK…
Grant US-9623029-B2
United States of America
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
Grant US-9611269-B2
United States of America
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCM…
Grant US-9498467-B2
United States of America
Processes and intermediates for making a JAK inhibitor
Grant US-9487521-B2
United States of America
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant US-9464088-B2
United States of America
Bipyrazole derivatives as JAK inhibitors
Grant US-9382231-B2
United States of America
Cyclohexyl azetidine derivatives as JAK inhibitors
Grant US-9359358-B2
United States of America
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and…
Grant US-9334274-B2
United States of America
Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
Grant US-9321755-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-9320732-B2
United States of America
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase…
Grant US-9249145-B2
United States of America
Phenyl amino pyrimidine compounds and uses thereof
Grant US-9238628-B2
United States of America
Phenyl amino pyrimidine compounds and uses thereof
Grant US-9233934-B2
United States of America
Processes and intermediates for making a JAK inhibitor
Grant US-9221845-B2
United States of America
3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK…
Grant US-9216984-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus…
Grant US-9206187-B2
United States of America
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as…
Grant US-9193733-B2
United States of America
Tricyclic fused thiophene derivatives as JAK inhibitors
Grant US-9181271-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus…
Grant US-9079912-B2
United States of America
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
Grant US-9034884-B2
United States of America
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
Grant US-9023840-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-8993605-B2
United States of America
Processes and intermediates for making a JAK inhibitor
Grant US-8987443-B2
United States of America
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
Grant US-8951536-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus…
Grant US-8946245-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus…
Grant US-8933086-B2
United States of America
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
Grant US-8933085-B2
United States of America
Modulators of indoleamine 2,3-dioxygenase and methods of using the same
Grant US-8846726-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-8822511-B2
United States of America
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol…
Grant US-8822481-B1
United States of America
Phenyl amino pyrimidine bicyclic compounds and uses thereof
Grant US-8809359-B2
United States of America
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
Grant US-8796319-B2
United States of America
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Grant US-8765734-B2
United States of America
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and…
Grant US-8716303-B2
United States of America
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
Grant US-8691807-B2
United States of America
3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as jak…
Grant US-8604043-B2
United States of America
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus…
Grant US-8541425-B2
United States of America
Showing items 1–100